Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohrlich

Showing results (181-190 of 232) with videos related to

Pageof 24
Sort By:
Pediatric Hematology and Oncology|February 8, 2020
Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?Elie Cousin, Emmanuel Oger, Jean-Hugues Dalle, et al.
International Journal of Molecular Sciences|December 29, 2019
Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid LeukemiaThomas Cluzeau, Nathan Furstoss, Coline Savy, et al.
Nature Communications|May 23, 2013
Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channelsJuliette Albuisson, Swetha E Murthy, Michael Bandell, et al.
Oncotarget|May 18, 2017
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemiaValérie Vidal, Guillaume Robert, Laure Goursaud, et al.
Leukemia|September 24, 2010
NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951E Clappier, S Collette, N Grardel, et al.
Orphanet Journal of Rare Diseases|September 27, 2012
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia RegistrySarah Beaussant Cohen, Odile Fenneteau, Emmanuel Plouvier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2019
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyPedro H Prata, Matthieu Resche-Rigon, Didier Blaise, et al.
Psycho-Oncology|October 29, 2022
Quality of life of long-term childhood acute lymphoblastic leukemia survivors: Comparison with healthy controlsSofia Chantziara, Jammbe Musoro, Alison C Rowsell, et al.
Pediatric Blood & Cancer|November 30, 2024
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of InstrumentsJammbe Musoro, Charlotte Sleurs, Ali Rowsell, et al.
Blood|December 11, 2012
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemiaMarlène Pasquet, Christine Bellanné-Chantelot, Suzanne Tavitian, et al.
Pageof 24

Showing results (181-190 of 232) with videos related to

Sort By:
Pageof 24
Pediatric Hematology and Oncology|February 8, 2020
Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?Elie Cousin, Emmanuel Oger, Jean-Hugues Dalle, et al.
International Journal of Molecular Sciences|December 29, 2019
Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid LeukemiaThomas Cluzeau, Nathan Furstoss, Coline Savy, et al.
Nature Communications|May 23, 2013
Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channelsJuliette Albuisson, Swetha E Murthy, Michael Bandell, et al.
Oncotarget|May 18, 2017
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemiaValérie Vidal, Guillaume Robert, Laure Goursaud, et al.
Leukemia|September 24, 2010
NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951E Clappier, S Collette, N Grardel, et al.
Orphanet Journal of Rare Diseases|September 27, 2012
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia RegistrySarah Beaussant Cohen, Odile Fenneteau, Emmanuel Plouvier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2019
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyPedro H Prata, Matthieu Resche-Rigon, Didier Blaise, et al.
Psycho-Oncology|October 29, 2022
Quality of life of long-term childhood acute lymphoblastic leukemia survivors: Comparison with healthy controlsSofia Chantziara, Jammbe Musoro, Alison C Rowsell, et al.
Pediatric Blood & Cancer|November 30, 2024
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of InstrumentsJammbe Musoro, Charlotte Sleurs, Ali Rowsell, et al.
Blood|December 11, 2012
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemiaMarlène Pasquet, Christine Bellanné-Chantelot, Suzanne Tavitian, et al.
Pageof 24